Search results
Results From The WOW.Com Content Network
A summary of CHOP upstream and downstream pathways. The PERK-ATF4-CHOP pathway can induce apoptosis by binding to the death receptors and upregulating the expression of death receptor 4 (DR4) and DR5. CHOP also interacts with the phosphorylated transcription factor JUN to form a complex that binds to the promoter region of DR4 in lung cancer ...
Status migrainosus. 3 languages. ... Download as PDF; Printable version; In other projects Wikidata item; Appearance. move to sidebar hide. From Wikipedia, the free ...
A migraine attack lasting longer than 72 hours is termed status migrainosus. [30] There are four possible phases to a migraine attack, although not all the phases are necessarily experienced: [31] The prodrome, which occurs hours or days before the headache; The aura, which immediately precedes the headache; The pain phase, also known as ...
When attacks last longer than this, it is known as "status migrainosus," which is what Judd experienced. "Unfortunately, many people mistake migraine for ‘regular headaches,’ and are unaware ...
Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...
Persistent aura without infarction (PAWOI) is a rare and seemingly benign [1] condition, first described in case reports in 1982 as "prolonged/persistent migraine aura status", [2] and in 2000 as "migraine aura status", [3] [4] that is not yet fully understood.
The following diagram is provided as an overview of and topical guide to the human nervous system: Human nervous system. Human nervous system – the part of the human body that coordinates a person's voluntary and involuntary actions and transmits signals between different parts of the body.
Triptans are a mid-line treatment suitable for many migraineurs with typical attacks. They may not work for atypical or unusually severe migraine attacks, transformed migraine, or status migrainosus (continuous migraine). Triptans are highly effective, reducing the symptoms or aborting the attack within 30 to 90 minutes in 70–80% of patients. [6]